Baicheng Pharmaceutical (301096.SZ) has reached an agreement on authorized cooperation with Zhongshen Innovation on the innovative drug BIOS-0629 project.

Capital Eye Financial News App News, Baicheng Pharmaceuticals (301096.SZ) announced that the company has reached an exclusive cooperation agreement in the Greater China region with Zhejiang Zhongshen Innovative Pharmaceutical Technology Co., Ltd. (referred to as "Zhongshen Innovation") on the innovative drug BIOS-0629 project of Class 1, and signed a "Technology Development Cooperation Agreement" and supplementary agreement.